XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Xenetic Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.93−0.06 (-3.02%)
Close on Oct 19, 2026
- Market cap
- $4.43M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 10, 2023(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 15, 2023 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jun 25, 2019 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Jun 25, 2019 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Aug 15, 2016(first seen in filings) | 1-for-33 reverse | Earlier per-share figures multiplied by 33 |
| Apr 22, 2013(first seen in filings) | 10-for-1 | Earlier per-share figures divided by 10 |